Back
Sportradar Group AG Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
57
SRAD
Sportradar Group AG
Last Price:
$23.79
Seasonality Move:
6.42%
Buy
70
KYMR
Kymera Therapeutics, Inc.
Last Price:
$77.72
Seasonality Move:
-9.68%
Buy
57
Sportradar Group AG (SRAD)
is a Buy
Is Sportradar Group AG a Buy, Sell or Hold?
-
The current Sportradar Group AG [SRAD] share price is $24.17. The Score for SRAD is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $78.12. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRAD Stock Price Chart
What is Sportradar Group AG's stock price today?
-
The Sportradar Group AG share price today is $24.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRAD is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $78.12The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
SRAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.53 | Buy |
| Relative Strength Index (14 RSI): | 62.76 | Buy |
| Chaikin Money Flow: | 1743441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.43 | Buy |
| Relative Strength Index (14 RSI): | 50.99 | Buy |
| Chaikin Money Flow: | -282062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
SRAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.25 | Buy |
| 20-day SMA: | 22.98 | Buy |
| 50-day SMA: | 23.55 | Buy |
| 200-day SMA: | 25.64 | Sell |
| 8-day EMA: | 20.97 | Buy |
| 20-day EMA: | 13.82 | Buy |
| 50-day EMA: | 7.02 | Buy |
| 200-day EMA: | 2 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.8 | Sell |
| 20-day SMA: | 80.9 | Sell |
| 50-day SMA: | 69.78 | Buy |
| 200-day SMA: | 48.08 | Buy |
| 8-day EMA: | 81.33 | Sell |
| 20-day EMA: | 79.47 | Sell |
| 50-day EMA: | 71.69 | Buy |
| 200-day EMA: | 54.23 | Buy |
Sportradar Group AG Earnings Growth & SRAD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.30 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.36 per share.
Sportradar Group AG Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||